Deals and Projects

Rymarz Zdort advised ExploRNA Therapeutics in the course of an equity investment by Black Forest

30 March 2021

Rymarz Zdort advised ExploRNA Therapeutics in the process of an equity investment that involved a subscription for shares in ExploRNA Therapeutics by the fund Black Forest SICAV-SIF (owned by Michał Sołowow) and the provision of funds for the expansion of the former’s operations.

ExploRNA Therapeutics is a biotech spin-off company of the University of Warsaw, which develops ground-breaking mRNA modification technologies paving the way for new therapeutic applications of mRNA in medicine, such as COVID-19 vaccines.

Black Forest SICAV-SIF is an investment fund supporting scientific and technological advancements achieved by both Polish and foreign companies. Active in a number of industries and sectors, Black Forest’s net asset value has now exceeded EUR 4.1 billion. Products manufactured by its companies are sold throughout the world (in more than 60 countries, in six continents).

The investment by Black Forest SICAV-SIF will allow ExploRNA Therapeutics to develop and implement an ambitious research program focusing on the use of mRNA for therapeutic purposes and enhancing the company’s research potential.

The transaction team included Paweł Zdort, a managing partner, and Krystian Kowalski, an associate of the corporate z department.

Team members

Paweł Zdort

Paweł Zdort

Managing Partner

Paweł Zdort

More news

Rymarz Zdort Maruta advises Stokado on acquisition of Top Box

15 November 2023

We are pleased to announce that we advised Stokado on the acquisition of the self-storage rental company Top Box. Stokado's current leasable space stands at over 20,000 square metres. The acquisition ...

Rymarz Zdort Maruta advises Stokado on acquisition of Top Box

Renowned Life Sciences legal team joins Rymarz Zdort Maruta 

9 November 2023

The law firm of Rymarz Zdort Maruta, in line with its strategy, is continuing its dynamic growth by expanding the scope of support it provides to also cover the Life Sciences sector. Over the coming m...

Renowned Life Sciences legal team joins Rymarz Zdort Maruta 
STAY UP TO DATE!
SUBSCRIBE TO 
OUR NEWSLETTER

Confirm your email

Check your mailbox and click the link to confirm your subscription to our Newsletter.

Thank you!